NCT03509558

Brief Summary

Growing evidence indicates that electrical spinal cord stimulation improves motor functions both immediately and over the long term via modulating the excitability of spinal circuitry in patients with spinal cord injury. Recently, a novel, non-invasive, well-tolerated, and painless lumbosacral transcutaneous electrical stimulation strategy was demonstrated to be effective in improving lower limb motor function in participants with spinal cord injury. Our current project, cervical transcutaneous electrical stimulation and intensive exercise for arms and hands are also revealing a significant improvement in upper extremity function. Additionally, the subject and caregiver noted that stair climbing ability has been substantially enhanced starting from the first week of cervical stimulation treatment and continues to date. This study is a prospective efficacy trial of combined transcutaneous cervical and lumbosacral electrical stimulation with physical therapy for improving locomotion in people with anatomically incomplete tetraplegia and paraplegia. This experiment design consists of testing walking function with and without transcutaneous spinal cord stimulation. A two to four-phase intervention program will include physical therapy and spinal cord stimulation with physical therapy. The length of any intervention phase, and number of measurements performed during that phase, will be determined by multiple factors, including participants' health condition, availability, and response to intervention. Between each intervention, washout periods of up to one month may be used to determine any after-effects of the interventions. The intervention arms will be repeated if the functional improvement does not reach a plateau during the first two months of intervention. Physical therapy will include functional training (e.g., walking training) and strength training. Each spinal cord stimulation with physical therapy intervention block can use transcutaneous lumbosacral stimulation or cervical and lumbosacral stimulation. Both immediate and lasting improvements in lower extremity function and autonomic function via transcutaneous spinal cord stimulation and intensive physical therapy may be evaluated.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
5mo left

Started Feb 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Feb 2018Sep 2026

Study Start

First participant enrolled

February 28, 2018

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

March 24, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 26, 2018

Completed
7.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Expected
Last Updated

August 5, 2025

Status Verified

March 1, 2025

Enrollment Period

7.6 years

First QC Date

March 24, 2018

Last Update Submit

July 31, 2025

Conditions

Keywords

Spinal electrical stimulation

Outcome Measures

Primary Outcomes (2)

  • Six-Minute Walk Test

    Measurement of walking ability. The distance is reported in meter.

    1-11 months

  • Two-minute walk test

    A measurement of endurance that assesses walking distance over two minutes.

    1-11 months

Secondary Outcomes (15)

  • International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) Examination

    1-11 months

  • Somatosensory evoked potentials

    1-11 months

  • Somatosensory evoked potentials

    1-11 months

  • Motor evoked potentials

    1-11 months

  • Motor evoked potentials

    1-11 months

  • +10 more secondary outcomes

Study Arms (2)

Transcutaneous spinal stimulation & Physical therapy

ACTIVE COMPARATOR

Transcutaneous electrical stimulation combined with physical therapy that targets rehabilitation of walking and standing functions

Device: Transcutaneous spinal stimulationOther: Physical Therapy

Physical therapy only

ACTIVE COMPARATOR

Physical therapy that targets rehabilitation of walking and standing functions

Other: Physical Therapy

Interventions

Non-invasive electrical stimulation of spinal cord over the skin combined with physical therapy to improve walking and standing functions

Also known as: Physical Therapy
Transcutaneous spinal stimulation & Physical therapy

physical therapy to improve walking and standing functions

Physical therapy onlyTranscutaneous spinal stimulation & Physical therapy

Eligibility Criteria

Age21 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Has spinal cord injury (T12 or higher level) of at least 1-year duration
  • Is between 21 and 70 years of age
  • Has difficulty with leg functions and mobility in activities of daily living (e.g. walking, transferring surface to surface, standing)
  • Has stable medical condition without cardiopulmonary disease or frequent autonomic dysreflexia that would contraindicate participation in lower extremity rehabilitation or testing activities
  • Is capable of performing simple cued motor tasks
  • Has ability to attend up to 5 sessions per week physical therapy sessions and testing activities
  • Has adequate social support to be able to participate in training and assessment sessions, up to 5 sessions per week, for the duration of up to 11 months within the study period
  • Is volunteering to be involved in this study
  • Cleared for gait training by the primary physician of the subject
  • Has the ability to read and speak English

You may not qualify if:

  • Has autoimmune etiology of spinal cord dysfunction/injury
  • Has history of additional neurologic disease, such as stroke, multiple sclerosis, traumatic brain injury, etc.
  • Has peripheral neuropathy (diabetic polyneuropathy, entrapment neuropathy, etc.)
  • Has rheumatic diseases (rheumatoid arthritis, systemic lupus erythematosus, etc.)
  • Has significant medical disease; including uncontrolled systemic hypertension with values above 170/100 mmHg; cardiac or pulmonary disease; uncorrected coagulation abnormalities or need for therapeutic anticoagulation.
  • Has active cancer
  • Has cardiovascular or musculoskeletal disease or injury that would prevent full participation in physical therapy intervention
  • Has unhealed fracture, contracture, pressure sore, urinary tract infection, or other illnesses that might interfere with lower extremity rehabilitation or testing activities
  • Has any condition that would render the patient unable to safely cooperate with the study tests as judged by the screening physician
  • is pregnant
  • is dependent on ventilation support
  • Has implanted stimulator (e.g. epidural stimulator, vagus nerve stimulator, pacemaker, cochlear implant, etc)
  • Has depression or anxiety based on the Center for Epidemiologic Studies Depression Scale (CESD) (score \>16/60) and General Anxiety Disorder-7 item Questionnaire (score \>9/21), respectively
  • Has alcohol and/or drug abuse
  • Has cognitive impairment based on Short Portable Mental Status Questionnaire (SPMSQ) (score \>2/10)
  • +14 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Washington

Seattle, Washington, 98195, United States

RECRUITING

MeSH Terms

Conditions

Spinal Cord Injuries

Interventions

Physical Therapy Modalities

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitation

Central Study Contacts

Soshi Samejima, DPT, MS

CONTACT

Chet Moritz, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 24, 2018

First Posted

April 26, 2018

Study Start

February 28, 2018

Primary Completion

September 30, 2025

Study Completion (Estimated)

September 30, 2026

Last Updated

August 5, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations